QuidelOrtho Corp. Stock
QuidelOrtho Corp. Stock
A very strong showing by QuidelOrtho Corp. today, with an increase of €1.00 (4.200%) compared to yesterday's price.
Based on 3 Buy predictions and 2 Sell predictions the sentiment towards QuidelOrtho Corp. is rather balanced.
With a target price of 30 € there is a slightly positive potential of 20.0% for QuidelOrtho Corp. compared to the current price of 25.0 €.
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | 4.200% | 8.696% | 1.626% | -39.614% | 0.000% | -70.238% | -86.911% |
| Veeva Systems A | -0.250% | -11.428% | -13.744% | -28.082% | -15.614% | -2.167% | -33.278% |
| Illumina Inc. | -0.740% | -9.453% | -0.924% | -5.048% | -0.595% | -42.782% | -68.286% |
| Waters Corp. | -1.320% | 1.055% | -0.061% | -17.565% | -0.641% | 2.939% | 39.188% |
Comments
QuidelOrtho (NASDAQ:QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $22.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $38.00 to $25.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
On November 14, New York City-based Newtyn Management disclosed a purchase of 994,332 shares of QuidelOrtho Corporation (QDEL), increasing its stake by approximately $30.4 million.
According to a
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats
QuidelOrtho (NASDAQ:QDEL), a global provider of diagnostic testing solutions, released its financial results for the quarter ended June 29, 2025, on August 5, 2025. The most notable headline was a